Acadia Pharmaceuticals (ACAD) Change in Account Payables (2010 - 2026)

Acadia Pharmaceuticals' Change in Account Payables history runs 17 years deep, the most recent figure standing at $1.3 million for Q1 2026.

• In Q1 2026, Change in Account Payables fell 29.43% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at -$5.8 million (down 372.84% YoY), while the FY2025 annual figure was -$5.3 million, down 291.49% from the prior year.
• Change in Account Payables was $1.3 million for Q1 2026 at Acadia Pharmaceuticals, up from -$10.8 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $5.2 million in Q4 2023 to a low of -$10.8 million in Q4 2025.
• Historically, Change in Account Payables has averaged $315882.4 across 5 years, with a median of $1.4 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Change in Account Payables jumped 993.26% in 2022, then slumped 275.35% in 2025.
• A 5-year view of Change in Account Payables shows it stood at $2.7 million in 2022, then jumped by 91.12% to $5.2 million in 2023, then plunged by 155.21% to -$2.9 million in 2024, then plunged by 275.35% to -$10.8 million in 2025, then soared by 112.38% to $1.3 million in 2026.
• The last three Change in Account Payables figures came in at $1.3 million (Q1 2026), -$10.8 million (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.